Omada Health OMDA Estimates

NASDAQ OMDA
$22.77 +0.48 (+2.15%)
At close: Sep 4, 2026 · 4:00 PM EDT
Analyst Estimates

Omada Health, Inc. Revenue Estimates

Periods 24
Next Period Q3 26
Consensus 81.33 M

Analysts expect Omada Health, Inc. to report revenue of 81.33 M for Q3 26, against a range of 74.24 M to 88.42 M. The most recent reported quarter, Q2 26, came in at 87.83 M, a 16.6% beat against the 75.30 M consensus.

Metric Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 54.96 M61.37 M68.03 M75.85 M78.05 M87.83 M--------
High Estimate -60.23 M62.73 M75.04 M75.03 M80.02 M88.42 M99.07 M104.42 M101.58 M118.28 M120.61 M128.02 M139.86 M
Low Estimate -52.89 M55.70 M69.69 M63.00 M70.58 M74.24 M85.19 M98.03 M90.72 M99.51 M100.18 M106.06 M120.38 M
Consensus Estimate -56.56 M59.22 M72.37 M69.01 M75.30 M81.33 M92.13 M101.22 M96.15 M108.89 M110.40 M117.04 M130.12 M
Analyst Estimates

Omada Health, Inc. Earnings Per Share (EPS) Estimates

Periods 20
Next Period Q3 26
Consensus 0.08

Analysts expect Omada Health, Inc. to report earnings per share of 0.08 for Q3 26, against a range of 0.07 to 0.09. The most recent reported quarter, Q2 26, came in at 0.18, a 200.0% beat against the 0.06 consensus.

Metric Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) -0.13-0.24-0.060.080.040.18--------
High Estimate --0.11-0.070.01-0.110.060.090.10-0.010.110.170.170.080.20
Low Estimate --0.13-0.090.01-0.130.060.070.10-0.010.110.150.150.060.18
Consensus Estimate --0.12-0.080.01-0.120.060.080.10-0.010.110.160.160.070.19